These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33217679)

  • 1. Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications.
    Restaino S; Tortorella L; Dinoi G; Zannoni GF; Baroni A; Capasso I; Distefano E; Sozzi G; Chiantera V; Scambia G; Fanfani F
    Eur J Cancer; 2021 Jan; 142():29-37. PubMed ID: 33217679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
    Ronsini C; Anchora LP; Restaino S; Fedele C; Arciuolo D; Teodorico E; Bizzarri N; Zannoni GF; Ferrandina G; Scambia G; Fanfani F
    Gynecol Oncol; 2021 Aug; 162(2):299-307. PubMed ID: 34116834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: A systematic review and meta-analysis.
    Han L; Chen Y; Zheng A; Tan X; Chen H
    Gynecol Oncol; 2024 May; 184():198-205. PubMed ID: 38335803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer.
    Tortorella L; Restaino S; Zannoni GF; Vizzielli G; Chiantera V; Cappuccio S; Gioè A; La Fera E; Dinoi G; Angelico G; Scambia G; Fanfani F
    J Gynecol Oncol; 2021 Mar; 32(2):e11. PubMed ID: 33470061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
    Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
    Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
    J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
    Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Substantial Lymphovascular Space Invasion Prognostic in Patients With Pathologically Lymph Node-Negative Endometrial Cancer?
    Pifer PM; Jaishankar S; Bhargava R; Schad MD; Keller A; Musunuru HB; Cohen M; Sukumvanich P; Courtney-Brooks M; Boisen M; Berger JL; Olawaiye A; Lesnock J; Edwards R; Taylor S; Vargo JA; Beriwal S
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):148-153. PubMed ID: 36893818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study.
    Pifer PM; Bhargava R; Patel AK; Ling DC; Vargo JA; Orr BC; Sukumvanich P; Courtney-Brooks MB; Boisen MM; Berger JL; Taylor S; Olawaiye AB; Comerci JT; Lesnock JL; Edwards RP; Beriwal S
    Gynecol Oncol; 2020 Oct; 159(1):23-29. PubMed ID: 32718729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.
    Briët JM; Hollema H; Reesink N; Aalders JG; Mourits MJ; ten Hoor KA; Pras E; Boezen HM; van der Zee AG; Nijman HW
    Gynecol Oncol; 2005 Mar; 96(3):799-804. PubMed ID: 15721428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
    Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
    Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The grading of lymphovascular space invasion in endometrial carcinoma.
    Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M
    Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
    Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
    Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
    Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
    Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.